{
 "as_of": "2026-11-06",
 "cmr": "jp-cm-kg/TSE-GROWTH/4582",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# SymBio Pharmaceuticals Limited (Growth Market: 4582) — research page\n\nAs of 2026-11-06 · jp-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is SymBio Pharmaceuticals Limited, listed on the Growth Market under ticker 4582. The ISIN is not on the record, and the LEI is not on the record. The security type is Corporate, the sector is 3250 Pharmaceutical, and the jurisdiction is Japan (EDINET domestic filer). The segment is not on the record. The issuer is listed and not halted.\n\n## The disclosure read\n\nThe record holds 10 filings in the twelve months to 2026-11-06, across 6 filing days. Of these, 2 are ad hoc, 2 are prospectus, 4 are regulatory filing, and 2 are results. The median gap between filing days is 7 days. The latest filing is dated 2026-08-21 and is a prospectus, 77 days before the record date. The Growth Market median is 42 days between filing days, 8.0 filings, and 85.0 days of latency across 598 issuers. The sector median on this market is 49.5 days between filing days, 8.0 filings, and 85.0 days of latency across 80 issuers.\n\n## Auditor\n\nThe auditor of record is EY新日本有限責任監査法人. Its location is not on the record. Auditor changes are not on the record, as the market's record does not carry them.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag shows the issuer as listed, not halted.\n\n## Orderability\n\nFor the client category Qualified Institutional Investors the outcome is not determinable, because the subject's class carries no CFI to place on the scope bridge and no scope object names the class, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations page as read, and the count is 0.\n\n## Open research\n\nTwo openly published research notes are on the record. Shared Research Inc. published on 2025-08-18, and Edison Investment Research Limited published on 2016-03-21.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed, the earliest sealed date of the market is not on the record, and the date when the live record began is not on the record.\n\n## Sources\n\n9 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)\n- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)\n- https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4582 (the disclosure lines)\n- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)\n- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XNE5 (the auditor)\n- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.symbiopharma.com/en/ir/pdf/4582_EN_20250818.pdf (open research)\n- https://www.symbiopharma.com/ir/pdf/symbio_pharmaceuticals_20160321e.pdf (open research)\n- https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4582 (the record)\n",
 "market": "JP",
 "node": "jp-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the JP vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "read_by": "EDINET XBRL-to-CSV facts (API v2 type=5, 有価証券報告書 docTypeCode 120) — element jpcrp_cor:AuditFirm1Consolidated",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XNE5",
    "state": "sourced",
    "value": "EY新日本有限責任監査法人"
   },
   "auditor_firm_id": {
    "market": "JP",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "JP",
    "state": "not_on_record"
   },
   "changes": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "jp-cm-kg/TSE-GROWTH/4582",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 598,
     "median_cadence_gap_days": 42,
     "median_filings": 8,
     "median_latency_days": 85,
     "name": "Growth Market"
    },
    "sector": {
     "issuers": 80,
     "median_cadence_gap_days": 49.5,
     "median_filings": 8,
     "median_latency_days": 85,
     "name": "3250 Pharmaceutical"
    }
   },
   "by_type": {
    "ad_hoc": 2,
    "prospectus": 2,
    "regulatory_filing": 4,
    "results": 2
   },
   "cadence_median_gap_days": 7,
   "filing_days": 6,
   "filings": 10,
   "latency_days": 77,
   "latest": [
    {
     "category": "040",
     "date": "2026-08-21",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YXVZ",
     "title": "訂正有価証券届出書（参照方式）",
     "type": "prospectus"
    },
    {
     "category": "有価証券届出書 (securities registration statement)",
     "date": "2026-08-17",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YWCL",
     "title": "有価証券届出書（参照方式）",
     "type": "prospectus"
    },
    {
     "category": "135",
     "date": "2026-08-10",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YVT2",
     "title": "確認書",
     "type": "regulatory_filing"
    },
    {
     "category": "半期報告書 (half-year report)",
     "date": "2026-08-10",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YVSZ",
     "title": "半期報告書－第22期(2026/01/01－2026/12/31)",
     "type": "results"
    },
    {
     "category": "190",
     "date": "2026-04-17",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XZH8",
     "title": "訂正臨時報告書",
     "type": "regulatory_filing"
    }
   ],
   "latest_filing_date": "2026-08-21",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4582",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Growth Market"
   },
   "isin": {
    "market": "JP",
    "reason": "no LEI, so no GLEIF ISIN route",
    "state": "not_on_record"
   },
   "jurisdiction": {
    "read_by": "EDINET code list (Edinetcode.zip, filer master with corporate number) (提出者種別)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip",
    "state": "sourced",
    "value": "Japan (EDINET domestic filer)"
   },
   "lei": {
    "market": "JP",
    "reason": "no GLEIF record registered as 0104-01-057034 (RA000412)",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "SymBio Pharmaceuticals Limited"
   },
   "sector": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English) (33-sector classification)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "3250 Pharmaceutical"
   },
   "security_type": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "JP",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "4582"
   },
   "website": {
    "market": "JP",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "JP",
  "node": "jp-cm-kg",
  "numbers_hash": "sha256:15f50cb7e13832f4f38699408e6d26d37a1bfb2037d05e3d7da38a862dff7e89",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [
    {
     "date": "2025-08-18",
     "kind": "issuer-sponsored",
     "publisher": "Shared Research Inc.",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://www.symbiopharma.com/en/ir/pdf/4582_EN_20250818.pdf",
     "state": "sourced",
     "title": "Research Coverage Report by Shared Research Inc."
    },
    {
     "date": "2016-03-21",
     "kind": "issuer-sponsored",
     "publisher": "Edison Investment Research Limited",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://www.symbiopharma.com/ir/pdf/symbio_pharmaceuticals_20160321e.pdf",
     "state": "sourced",
     "title": "SymBio Pharmaceuticals"
    }
   ],
   "state": "found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Qualified Institutional Investors"
   ],
   "outcomes": {
    "Qualified Institutional Investors": {
     "determinable": false,
     "reason": "the rule states a product scope; the subject's class carries no CFI to place on the scope bridge, and no scope object names the class: the subject is not shown within the scope",
     "signal": null
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.jp-cm-kg.ai/book/aio.json",
    "door": "https://mcp.jp-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/jp/suitability-principle-fiea-article-40/r1",
   "section": "jp.aio.v6"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4582",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:15f50cb7e13832f4f38699408e6d26d37a1bfb2037d05e3d7da38a862dff7e89",
 "path": "/jp/TSE-GROWTH/4582",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is SymBio Pharmaceuticals Limited, listed on the Growth Market under ticker 4582. The ISIN is not on the record, and the LEI is not on the record. The security type is Corporate, the sector is 3250 Pharmaceutical, and the jurisdiction is Japan (EDINET domestic filer). The segment is not on the record. The issuer is listed and not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 10 filings in the twelve months to 2026-11-06, across 6 filing days. Of these, 2 are ad hoc, 2 are prospectus, 4 are regulatory filing, and 2 are results. The median gap between filing days is 7 days. The latest filing is dated 2026-08-21 and is a prospectus, 77 days before the record date. The Growth Market median is 42 days between filing days, 8.0 filings, and 85.0 days of latency across 598 issuers. The sector median on this market is 49.5 days between filing days, 8.0 filings, and 85.0 days of latency across 80 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is EY新日本有限責任監査法人. Its location is not on the record. Auditor changes are not on the record, as the market's record does not carry them.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag shows the issuer as listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "For the client category Qualified Institutional Investors the outcome is not determinable, because the subject's class carries no CFI to place on the scope bridge and no scope object names the class, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations page as read, and the count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "Two openly published research notes are on the record. Shared Research Inc. published on 2025-08-18, and Edison Investment Research Limited published on 2016-03-21.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed, the earliest sealed date of the market is not on the record, and the date when the live record began is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "9 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4582"
  },
  {
   "for": "the halt flag",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html"
  },
  {
   "for": "the auditor",
   "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XNE5"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.jp-cm-kg.ai/book/aio.json"
  },
  {
   "for": "open research",
   "source": "https://www.symbiopharma.com/en/ir/pdf/4582_EN_20250818.pdf"
  },
  {
   "for": "open research",
   "source": "https://www.symbiopharma.com/ir/pdf/symbio_pharmaceuticals_20160321e.pdf"
  },
  {
   "for": "the record",
   "source": "https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4582"
  }
 ],
 "title": "SymBio Pharmaceuticals Limited (4582) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}